Investment Rating - The report maintains a "Buy" rating for the real estate development sector and real estate services sector [10][14]. Core Insights - The report highlights a rebound in new home sales in 44 cities, with a week-on-week increase of 22%, while second-hand home sales saw a slight decline of 5% [2]. - Year-to-date, new home sales in 44 cities are down 6% year-on-year, while second-hand home sales are up 14% [2]. - The report emphasizes the importance of inventory reduction, noting a 0.4% decrease in new home inventory in 21 key cities [33]. Summary by Sections Market Overview - The Shanghai Composite Index fell by 1.75%, with the real estate development sector down 3.43% [3]. - The report indicates a mixed performance in the real estate market, with new home sales showing signs of recovery while second-hand sales are declining [2][3]. Key Companies and Dynamics - The report recommends several companies for investment, including: - Chengdu Investment Holdings (600649 CH) with a target price of 6.34 - Chengjian Development (600266 CH) with a target price of 7.32 - Binjiang Group (002244 CH) with a target price of 12.08 - China Overseas Development (688 HK) with a target price of 17.07 - Greentown China (3900 HK) with a target price of 12.73 - China Overseas Property (2669 HK) with a target price of 7.74 - Link REIT (823 HK) with a target price of 50.59 [11][43]. New Home and Second-Hand Home Data - New home sales in July across 44 cities decreased by 19% year-on-year, with first-tier cities down 26% [15]. - The report notes that second-hand home sales in 22 cities decreased by 6% in July, but year-to-date, they are up 14% [24]. Inventory and Market Dynamics - As of July 27, the inventory of new homes in 21 key cities decreased by 0.4% week-on-week, with a year-on-year decline of 14% [33]. - The report indicates that the de-stocking speed in first-tier cities is 54 weeks, while second-tier cities are at 87 weeks [33]. Recommendations and Future Outlook - The report expresses optimism about the recovery of key city markets and the valuation recovery of companies with strong cash flow and performance [4][42]. - The report suggests that property management companies are also likely to see valuation recovery as the real estate market stabilizes [4].

Group 1: Market Overview - Recent market pullback primarily due to internal and external expectation adjustments, with the Hang Seng Index down 4.5% from its recent peak, compared to a 2.3% decline in the CSI 300[3] - External factors, such as rising US Treasury yields (up to 4.4%) and a strengthening US dollar (breaking the 100 mark), have exerted greater pressure on Hong Kong stocks compared to A-shares[5] - Southbound capital inflow surged to a net inflow of HKD 59 billion, marking the highest weekly inflow since April 11, 2025[6] Group 2: Investment Strategy - Emphasis on sectors with improving sentiment and low valuations, particularly in technology, gaming, and e-commerce leaders[2] - Recommended to focus on stocks with reasonable valuations and improving fundamentals, especially in the innovative pharmaceutical and non-bank financial sectors[7] - The report suggests a tactical approach centered around upcoming mid-year earnings reports, with a focus on companies expected to deliver strong earnings[7]

Economic Overview - The U.S. GDP growth for Q2 was revised up to 3.0%, exceeding expectations of 2.6%, with net exports contributing 5 percentage points[5] - The Atlanta Fed's GDP Now forecast indicates a slight decrease in Q3 GDP growth to 2.1%[3] - The final domestic private purchases growth (consumption + investment) fell by 0.7 percentage points to 1.2%[5] Employment Data - July non-farm payrolls increased by only 74,000, significantly below the expected 104,000, with prior months' data revised down by 258,000[5] - Initial jobless claims decreased by 23,000 to 193,000, better than the expected 211,000, indicating no significant layoffs yet[3] - The unemployment rate rose by 0.1 percentage points to 4.2%, primarily due to a drop in labor force participation[5] Inflation and Monetary Policy - The core PCE inflation for June was reported at 2.6%, above the expected 2.5%, indicating persistent inflationary pressures[5] - The Federal Reserve maintained the benchmark interest rate at 4.25%-4.5% during the July FOMC meeting, with a hawkish tone from Powell[6] Market Reactions - U.S. stock indices fell, with the S&P 500, Nasdaq, and Dow Jones down by 2.4%, 2.2%, and 2.9% respectively[7] - The U.S. dollar index rose by 1% to 98.7, while the euro and yen depreciated by 2.8% and 2.1% respectively[7] Commodity Prices - COMEX gold prices increased by 1.9% to $3,399.8 per ounce, while Brent crude oil rose by 1.8% to $69.7 per barrel[7]

Economic Activity - July export growth showed resilience with a year-on-year increase, while construction activity remained weak due to adverse weather conditions and policy adjustments[2] - Domestic passenger car sales fell significantly by 40.7% year-on-year during July 21-27, indicating a potential impact from high base effects[3] - The manufacturing PMI decreased from 49.7% in June to 49.3% in July, suggesting a contraction in manufacturing activity[8] Commodity Prices - Brent crude oil prices rose by 1.8% week-on-week to $69.7 per barrel, while COMEX gold prices increased by 2.3% to $3,360 per ounce[5] - Domestic copper and rebar prices fell by 1.3% and 3.1% respectively, indicating a general retreat in commodity prices[5] Real Estate Market - New home transaction area in 44 cities saw a year-on-year decline of 23.2%, worsening from a previous drop of 19.6%[60] - In first-tier cities, new home transaction areas decreased by 21.6% year-on-year, with significant declines in major cities like Beijing and Shanghai[60] - The average land transaction price in 100 cities increased by 91.8% week-on-week and 40.9% year-on-year, reflecting a divergence in market dynamics[60] Financial Market - Interbank liquidity tightened, with the RMB/USD exchange rate decreasing by 0.59% week-on-week[6] - The net issuance of government bonds rose to 672.4 billion yuan, a year-on-year increase of 66.8%[6]

Investment Rating - The report maintains an "Accumulate" rating for both A and H shares of the company [7] Core Views - The refining sector remains under pressure, with a forecasted decline in net profit for H1 2025 by 39.5%-43.7% year-on-year, primarily due to weak industry conditions [1] - The company's upstream performance is negatively impacted by a significant drop in international oil prices, with Brent crude averaging $66.7 per barrel in Q2 2025, down 21.5% year-on-year [2] - Domestic demand for refined oil products is being squeezed by the rise of new energy vehicles, leading to a decrease in gasoline and diesel consumption by 7.2% and 5.0% respectively in the first half of 2025 [3] - The chemical sector is facing margin pressure due to weak supply-demand dynamics, although capital expenditure is expected to stabilize, potentially leading to a market recovery [4] - The company's net profit forecasts for 2025-2027 have been revised downwards by 27% for 2025, reflecting the impact of lower oil prices and refining margins [5] Summary by Sections Financial Performance - The company expects a net profit of RMB 201-216 billion for H1 2025, with a significant drop in Q2 net profit anticipated at RMB 68-83 billion [1] - Oil processing volume decreased by 5.3% to 120 million tons in H1 2025, with total refined oil sales down 3.4% to 87.1 million tons [3] Production and Pricing - The company's crude oil production slightly decreased by 0.3% to 140 million barrels in H1 2025, while natural gas production increased by 5.1% to 736.3 billion cubic feet [2] - The average price of gasoline and diesel is expected to decline, with the company adjusting its sales volume and pricing assumptions accordingly [5][15] Capital Expenditure and Market Outlook - The chemical segment's capital expenditure is projected to remain stable at RMB 449 billion, focusing on ethylene and high-end materials [4] - The report suggests that the market may see a recovery as capital expenditure growth reaches a turning point, aided by policies aimed at optimizing supply dynamics [4] Valuation and Price Target - The target price for A shares is set at RMB 6.72 and for H shares at HKD 4.92, reflecting a valuation based on integrated advantages and a lower sensitivity to oil price fluctuations [5][8]

Investment Rating - The investment rating for the company is maintained as "Buy" with a target price of JPY 31,880, slightly down from the previous JPY 32,000 [1][8]. Core Views - The company has adjusted its full-year revenue and profit guidance for FY2026 down by 9.6% to JPY 2.35 trillion and by 21.6% to JPY 570 billion, respectively, primarily due to changes in customer capital expenditure plans [1][2]. - Despite the downward revision in revenue and profit forecasts, the company maintains its capital expenditure guidance for FY2026 at JPY 240 billion, reflecting ongoing investments in next-generation technologies driven by AI demand [2][3]. - The report highlights that the demand for AI chips remains strong, particularly for the Rubin series, which is expected to positively impact the company's performance in the semiconductor equipment sector [1][8]. Summary by Sections Financial Performance - For FY26Q1, the company reported revenue of JPY 549.5 billion, a year-on-year decrease of 1.0% and a quarter-on-quarter decrease of 16.1%, which was below Bloomberg consensus expectations [1]. - Operating profit for the same period was JPY 144.6 billion, down 12.7% year-on-year and 21.3% quarter-on-quarter, also missing consensus estimates [1]. - Net profit attributable to shareholders was JPY 117.8 billion, reflecting a year-on-year decline of 6.6% and a quarter-on-quarter decline of 17.6%, again below expectations [1]. Revenue and Profit Forecasts - The company has revised its revenue forecasts for FY26, FY27, and FY28 down by 11.7%, 11.9%, and 12.0%, respectively, and net profit forecasts down by 17.1%, 15.8%, and 16.1% [3][7]. - The adjustments are attributed to several factors, including the correction of capital expenditure plans by leading logic customers and a cautious approach to NAND investments [1][3]. Market Outlook - The global wafer fab equipment (WFE) market size forecast for CY2025 has been raised from USD 110 billion to USD 115 billion, reflecting currency fluctuations [2]. - The report anticipates significant increases in transistor counts and storage capacities for high-end AI server modules from CY2025 to CY2027, indicating robust growth potential in the AI-driven equipment market [2]. Valuation Metrics - The company’s estimated PE ratios for FY26 and FY27 are 25.47 and 22.63, respectively, with a target price based on a PE of approximately 26.4 times FY27E earnings [8][21]. - The report also provides a comparison of valuation metrics with peer companies, indicating a competitive position in the market [21].

Investment Rating - The report maintains a "Buy" rating for the company [7][5]. Core Views - The company reported a revenue of 13.569 billion RMB in 1H25, a year-on-year decrease of 10.84%, with a net profit attributable to shareholders of 564 million RMB, down 40.16% year-on-year [1][5]. - The decline in revenue is attributed to price pressures in the waterproofing segment, while new product categories and regions showed strong performance [2][5]. - The company is actively pursuing debt restructuring and asset protection through property acquisition, alongside ongoing overseas expansion efforts [4][5]. Summary by Sections Financial Performance - In 1H25, the company achieved revenues of 55.13 billion RMB from waterproofing materials, 39.46 billion RMB from coatings, 19.96 billion RMB from powder materials, and 11.38 billion RMB from other main businesses, with year-on-year changes of -8.84%, -17.11%, -6.24%, and +46.97% respectively [2][5]. - The gross profit margin for 1H25 was 25.4%, a decrease of 3.82 percentage points year-on-year, with specific margins of 22.60% for waterproofing materials, 36.54% for coatings, and 26.59% for powder materials [3][5]. - The company reported a net cash flow from operating activities of -396 million RMB in 1H25, an improvement of 930 million RMB year-on-year [3][5]. Debt and Asset Management - As of 1H25, the company had a debt restructuring book value of 840 million RMB and had transferred properties worth 2.34 billion RMB to secure asset safety [4][5]. - The company plans to distribute a cash dividend of 9.25 RMB per 10 shares, reflecting a commitment to shareholder returns [4][5]. Future Outlook - The revenue forecasts for 2025-2027 have been adjusted downwards by 4.9%, 5.4%, and 4.9% respectively, with net profit estimates reduced by 20.21%, 20.70%, and 17.31% [5][10]. - The target price has been revised to 13.80 RMB, corresponding to a 25x PE valuation for 2025 [5][8].

Investment Rating - The investment rating for the company is maintained as "Buy" with a target price of RMB 14.90 [1][7]. Core Views - The company achieved revenue of RMB 1.075 billion and a net profit attributable to the parent of RMB 34 million in 1H25, reflecting a year-on-year decline of 15.9% and 83.1% respectively, primarily due to adjustments in revenue structure and increased competition in the domestic market [1]. - The company's self-developed products generated revenue of RMB 872 million in 1H25, down 6.5% year-on-year, but the sales volume of self-developed reagents increased by 3.8% [1]. - The company has made significant progress in the commercialization of large instruments and production lines, with a total of 2,409 units shipped in 1H25, representing a year-on-year increase of 4.7% [1]. - The overseas market performance is strong, with overseas revenue reaching RMB 108 million in 1H25, up 37.6% year-on-year, and an increase in gross margin by 7.4 percentage points [1]. Summary by Sections Financial Performance - The company's gross margin for 1H25 was 57.0%, showing stability with a slight decrease of 0.04 percentage points year-on-year [2]. - The sales, management, and R&D expense ratios for 1H25 were 25.5%, 8.6%, and 14.2% respectively, reflecting increases of 3.1, 2.5, and 2.9 percentage points year-on-year [2]. Product Segments - Chemical luminescence reagents generated revenue of RMB 452 million in 1H25, down 6.2% year-on-year, but the sales volume increased by 9.6% [3]. - The company shipped 151 new immunoassay instruments and 846 new immune platform instruments in 1H25, contributing to a positive growth in instrument holdings [3]. - The company expects stable growth in chemical luminescence reagent revenue for the full year 2025, driven by increased instrument installations and favorable bidding outcomes [3]. Other Business Segments - Biochemical segment revenue was RMB 195 million in 1H25, down 25.2% year-on-year, attributed to price adjustments following inter-provincial alliance bidding [4]. - The clinical testing segment saw revenue of RMB 114 million in 1H25, up 6.2% year-on-year, with a significant increase in sales volume [4]. - Agency revenue decreased to RMB 193 million in 1H25, down 42.2% year-on-year, while the proportion of self-developed product revenue reached 81.1%, up 8.2 percentage points year-on-year [4]. Profit Forecast and Valuation - The company adjusted its profit forecast for 2025-2027, expecting EPS of RMB 0.35, 0.42, and 0.53, reflecting downward adjustments of 29%, 27%, and 24% respectively [5]. - The valuation method has switched to PE, with a target PE of 43x for 2025, compared to the industry average of 45x [5]. - The target price of RMB 14.90 reflects a revised estimate based on the company's self-developed and agency business contributions [5].

Core Insights - The report predicts that overseas Chinese stocks will experience a concentrated disclosure period for mid-2025 earnings in late August, with an expected earnings growth rate of 13% for the first half of 2025, up from 8% in 2024 [1][2][4] - The materials sector is expected to see significant improvement in earnings growth, while technology and healthcare sectors are likely to maintain high growth. However, consumer discretionary and energy sectors may face downward pressure on earnings growth [1][3][4] - As of July 30, 2025, the earnings forecast disclosure rate for overseas Chinese stocks is approximately 17%, with a current overall positive forecast rate of 60%, particularly strong in utilities, finance, and healthcare sectors [1][5] Industry Analysis - The materials sector, particularly construction and chemicals, is showing signs of earnings recovery due to easing capacity pressures and cost optimization. The technology and healthcare sectors continue to exhibit high growth [3][4] - Consumer discretionary and energy sectors are under pressure, with intense competition in e-commerce and automotive sectors potentially dragging down short-term earnings. The energy sector, dominated by industry giants, shows resilience against short-term fluctuations [3][4] - The telecommunications, consumer staples, finance, and utilities sectors are maintaining stable earnings, with notable sub-sectors such as diversified finance and transportation expected to see earnings acceleration [3][4] Tactical Allocation Recommendations - The report suggests increasing allocations to high-growth and value stocks in the gaming and internet e-commerce sectors, as these sectors are expected to benefit from improving market conditions and valuations [7][8] - Despite high valuations, innovative pharmaceuticals and non-bank financials are highlighted for their high earnings forecast rates and potential for upward revisions [8]

Investment Rating - The report maintains a "Buy" rating for the company with a target price of JPY 31,880, slightly down from the previous target of JPY 32,000 [6][4]. Core Views - The company has adjusted its FY26 revenue and operating profit guidance downwards by 9.6% to JPY 2.35 trillion and by 21.6% to JPY 570 billion, respectively, primarily due to changes in customer capital expenditure plans [2][4]. - Despite the downward revision in revenue and profit forecasts, the company remains optimistic about the demand for AI-related chips and the potential positive impact of the Rubin series on global semiconductor equipment performance [2][4]. - The company expects the global wafer fab equipment (WFE) market size for CY2025 to increase from USD 110 billion to USD 115 billion, reflecting the impact of currency fluctuations and the anticipated growth in AI server module capabilities [3][4]. Summary by Sections Financial Performance - For FY26Q1, the company's revenue was JPY 549.5 billion, a year-on-year decrease of 1.0% and a quarter-on-quarter decrease of 16.1%, which was below Bloomberg consensus expectations by 5.4% [1]. - Operating profit for the same period was JPY 144.6 billion, down 12.7% year-on-year and 21.3% quarter-on-quarter, also missing consensus expectations by 7% [1]. - Net profit attributable to shareholders was JPY 117.8 billion, a decline of 6.6% year-on-year and 17.6% quarter-on-quarter, falling short of consensus expectations by 11% [1]. Revenue and Profit Forecasts - The company has revised its FY26 revenue forecast down by 9.6% to JPY 2.35 trillion and operating profit down by 21.6% to JPY 570 billion, citing several factors including adjustments in capital expenditure by leading logic customers and reduced investments by emerging Chinese chip manufacturers [2][4]. - The report anticipates a continued strong demand for AI chips, particularly from companies like NVIDIA, which may drive performance in semiconductor equipment [2][4]. Capital Expenditure and R&D - The company maintains its capital expenditure guidance for FY26 at JPY 240 billion, significantly up from JPY 162.1 billion in FY25, with R&D expenses set at JPY 295 billion, reflecting ongoing investments in next-generation etching, deposition, and bonding equipment [3][4]. - The report highlights that the demand for advanced logic foundry services is expected to grow, particularly as TSMC continues to increase its capital expenditures while Intel and Samsung face challenges [2][4]. Valuation Metrics - The report projects a decline in FY26/27/28 operating revenue by 11.7%/11.9%/12.0% and a decrease in net profit attributable to shareholders by 17.1%/15.8%/16.1%, with diluted EPS expected to be JPY 1,073/1,208/1,342 [4][10]. - The company is valued at approximately 26.4 times FY27E PE, based on an average PE of 22.4 times for comparable companies [4][10].